Fungi play critical roles in the homeostasis of ecosystems globally and have emerged as
significant causes of an expanding repertoire of devastating diseases in plants, animals, and …

Pathogenic fungi are an increasing public health concern. The emergence of antifungal
resistance coupled with the scarce antifungal arsenal highlights the need for novel …

Candida auris, a multidrug-resistant human fungal pathogen, was first identified in 2009 in
Japan. Since then, systemic C. auris infections have now been reported in more than 50 …

Fungal infections present a significant global health challenge, prompting ongoing research
to discover innovative antifungal agents. The 110 kDa heat shock proteins (Hsp110s) are …

Introduction Candida species produce a wide array of infections ranging from
mucocutaneous to systemic infections. Candida albicans remains the most common species …

Most bacterial, plant and fungal cells possess at their surface a protective layer called the
cell wall, conferring strength, plasticity and rigidity to withstand the osmotic pressure. This …

One of the front-line drug classes used to treat invasive fungal infections is echinocandins,
which target the fungal-specific beta-glucan synthase (Fks). Treatment failure due to …

Fungal disease affects over a billion people worldwide. Naamidine A inhibits the growth of
diverse fungal pathogens through an unknown mechanism. Here, we show that the …

Despite advance on antifungal therapy in the past decade, the issues of fungal resistance
and a lack of effective treatments are still of major concern in clinical practice. Recently …

As a particularly serious condition in immunocompromised patients, fungal infections (FIs)
have increasingly become a public health problem worldwide. Mesenchymal stem cells …